From development to commercialization
MedTech Lifecycle Glossary
103 terms across device development, clinical evidence, manufacturing, supply chains, market access and postmarket monitoring — with plain-English definitions and primary sources.
Device category
103 of 103 terms shown
Device categories indicate topic relevance, not legal applicability. Cross-device terms remain included.
- 21 CFR Part 11 AI and software
21 CFR Part 11 sets FDA requirements for electronic records and electronic signatures to be trustworthy, reliable and equivalent to paper.
Cross-device relevance
Why it matters for founders: eQMS, ELN and clinical data systems that hold required records need validation, audit trails and access controls.
- 510(k)Premarket Notification Premarket
A 510(k) is an FDA premarket submission showing that a new device is substantially equivalent to a legally marketed predicate device.
Cross-device relevance
Why it matters for founders: It is the most common US route to market for moderate-risk (Class II) devices, and your predicate choice shapes your testing plan.
Related: Substantial Equivalence, Predicate Device, eSTAR, Q-Sub (Pre-Sub)
Buy the KitFDA Q-Sub Master Pack
$499 USD · One-time · Applicable taxes may apply
- Analytical Performance Development and clinical
Analytical performance describes how well a diagnostic test measures or detects its target analyte, including characteristics such as precision, detection limits, interference and analytical specificity, as applicable.
IVD and diagnostics
Why it matters for founders: Strong analytical results are necessary but do not alone prove clinical usefulness.
Related: In Vitro Diagnostic (IVD), Clinical Performance, Verification and Validation (V&V)
- Breakthrough Device Designation Premarket
Breakthrough Device Designation is an FDA program that offers more interactive review for devices that may provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating conditions.
Cross-device relevance
Why it matters for founders: Designation gives more frequent FDA interaction and prioritized review, but it does not lower the evidence standard for authorization.
Related: Q-Sub (Pre-Sub), De Novo, PMA
- CAPACorrective and Preventive Action Quality system
CAPA is the quality-system process for investigating the cause of nonconformities and complaints, correcting them and preventing them from recurring.
Cross-device relevance
Why it matters for founders: CAPA records are among the first things FDA investigators review, and weak CAPA is a frequent Form 483 observation.
Related: Form 483, QMSR, ISO 13485
Buy the KitQMSR Form 483 Response Kit
$299 USD · One-time · Applicable taxes may apply
- CDRHCenter for Devices and Radiological Health Premarket
CDRH is the FDA center responsible for regulating medical devices and radiation-emitting products in the United States.
Cross-device relevance
Why it matters for founders: CDRH review divisions handle your Q-Subs and premarket submissions, and its guidance documents define current expectations.
Related: Q-Sub (Pre-Sub), 510(k), PMA
- CE Marking Market access
CE marking shows that a device conforms to the EU MDR (or IVDR) and may be placed on the European Economic Area market.
Cross-device relevance
Why it matters for founders: It is not an FDA equivalent; US clearance and CE marking require separate evidence packages and reviews.
Related: EU MDR, Notified Body, UKCA
- Change Control Quality system
Change control is the documented review, approval and implementation of changes to products or quality-system processes, including assessment of risks, required testing and any regulatory submission impact.
Cross-device relevance
Why it matters for founders: A quality approval alone does not determine whether FDA needs a new submission.
Related: Design Controls, PCCP, Process Validation
Buy the KitPCCP-to-QMSR Mapping Kit
$199 USD · One-time · Applicable taxes may apply
- Clinical Evaluation Report (CER) Market access
Under the EU MDR, a clinical evaluation report documents the analysis of clinical data that demonstrates a device's safety, performance and clinical benefit.
Cross-device relevance
Why it matters for founders: Notified Bodies scrutinize the CER closely, and it must be updated with postmarket clinical follow-up data.
Related: EU MDR, Notified Body, Postmarket Surveillance
- Clinical Evidence Development and clinical
Clinical evidence is clinical data and its evaluation used to support a device's safety, performance or effectiveness for its intended use. What is sufficient depends on the device, claims and regulatory pathway.
Cross-device relevance
Why it matters for founders: The same evidence package may not satisfy regulators, clinicians and payers.
Related: IDE, Real-World Evidence (RWE), Clinical Evaluation Report (CER)
Buy the KitHospital VAC Dossier Pack
$299 USD · One-time · Applicable taxes may apply
- Clinical Performance Development and clinical
For an IVD, clinical performance describes how test results relate to the clinical condition or physiological state in the intended population, using measures appropriate to the claim such as clinical sensitivity and specificity.
IVD and diagnostics
Why it matters for founders: Your study population and reference method must support the diagnostic claim.
Related: In Vitro Diagnostic (IVD), Analytical Performance, Clinical Evidence
- Complaint Handling Risk and postmarket
Complaint handling is the documented process for receiving, reviewing and investigating reports that allege deficiencies in a device's identity, quality, durability, reliability, safety, effectiveness or performance.
Cross-device relevance
Why it matters for founders: Each complaint must be assessed for reportability, so weak complaint files lead to missed MDRs and inspection findings.
Related: MDR (Medical Device Reporting), CAPA, Postmarket Surveillance
Buy the Kit21 CFR to ISO 13485 Mapping Kit
$199 USD · One-time · Applicable taxes may apply
- Contract Manufacturing Manufacturing and supply chain
Contract manufacturing is production performed by an external organization for a device company. Outsourcing does not remove the device company's responsibility to control outsourced processes and meet applicable requirements.
Cross-device relevance
Why it matters for founders: Define quality responsibilities, change notifications and acceptance criteria before transferring production.
Related: Supplier Controls, Design Transfer, Medical Device Manufacturing
- Cost-to-charge ratio (CCR)Hospital cost-to-charge ratio Market access
A CCR describes the relationship between hospital costs and billed charges. CMS uses applicable hospital ratios in particular payment calculations; a national planning ratio is not every hospital's charge policy.
Cross-device relevance
Why it matters for founders: Device acquisition cost, billed charges and Medicare payment are different. A charge conversion does not determine collections, NTAP payment or profit.
Related: NTAP cost threshold, NTAP standardized case charges, Inpatient outlier payment
- CPT and HCPCS codes Market access
CPT and HCPCS are the US procedure and supply code sets that providers use to bill payers for services and devices.
Cross-device relevance
Why it matters for founders: FDA authorization does not guarantee payment; without a usable code, coverage and payment, hospitals may hesitate to buy.
Related: Value Analysis Committee (VAC)
Buy the KitReimbursement & Coding Roadmap
$299 USD · One-time · Applicable taxes may apply
- Cyber Device (Section 524B) AI and software
Under section 524B of the FD&C Act, a cyber device includes software, can connect to the internet and could be vulnerable to cybersecurity threats; its submissions must include cybersecurity information.
SaMD and AI · IVD and diagnostics · Electrical and connected devices
Why it matters for founders: Submissions must include a vulnerability monitoring plan, secure-design evidence and an SBOM, or FDA can refuse to accept them.
- De NovoDe Novo classification request Premarket
De Novo is an FDA pathway that classifies a novel low-to-moderate-risk device with no valid predicate into Class I or Class II.
Cross-device relevance
Why it matters for founders: A granted De Novo creates a new device type that later products, including competitors, can use as a 510(k) predicate.
Related: 510(k), Q-Sub (Pre-Sub), Predicate Device
Buy the KitFDA Q-Sub Master Pack
$499 USD · One-time · Applicable taxes may apply
- Design Controls Quality system
Design controls are the planned, documented checks — inputs, outputs, reviews, verification, validation, transfer and changes — that show a device was designed to meet user needs.
Cross-device relevance
Why it matters for founders: Design-control evidence feeds your submission and your DHF; reconstructing it after the fact is slow and costly.
Buy the Kit21 CFR to ISO 13485 Mapping Kit
$199 USD · One-time · Applicable taxes may apply
- Design Inputs Development and clinical
Design inputs are documented requirements for a device's function, performance, usability, safety and applicable regulatory requirements, informed by its intended use and user needs.
Cross-device relevance
Why it matters for founders: Clear, testable inputs make verification and design decisions traceable.
Related: Intended Use and Indications for Use, Design Outputs, Verification and Validation (V&V)
- Design Outputs Development and clinical
Design outputs are the documented results of design and development, such as specifications, drawings and software, that meet inputs and provide information for purchasing, production and service.
Cross-device relevance
Why it matters for founders: Outputs become the controlled instructions needed to make and test your product consistently.
Related: Design Inputs, Design Transfer, DMR
- Design Transfer Manufacturing and supply chain
Design transfer is the controlled translation of design outputs into suitable production specifications, with confirmation that production can meet product requirements.
Cross-device relevance
Why it matters for founders: A working prototype alone does not establish readiness for repeatable commercial production.
Related: Design Outputs, Medical Device Manufacturing, Process Validation
- Device Classification (Class I, II, III) Premarket
FDA places each device type into Class I, II or III based on its risk and the controls needed to provide reasonable assurance of safety and effectiveness.
Cross-device relevance
Why it matters for founders: Your class largely decides your pathway: most Class I devices are 510(k)-exempt, most Class II need a 510(k), and Class III usually needs a PMA.
Related: 510(k), De Novo, PMA, Product Code
- DHFDesign History File Quality system
A Design History File (DHF) is the compiled record showing how a device was designed and developed under design controls.
Cross-device relevance
Why it matters for founders: Under QMSR the term maps to the ISO 13485 design and development file, but investigators still expect complete, traceable design records.
Related: Design Controls, DMR, DHR, QMSR
Buy the Kit21 CFR to ISO 13485 Mapping Kit
$199 USD · One-time · Applicable taxes may apply
- DHRDevice History Record Quality system
A Device History Record (DHR) is the production record showing that each batch, lot or unit was manufactured according to its approved specifications.
Cross-device relevance
Why it matters for founders: Under QMSR these become ISO 13485 batch/production records, which must still trace each unit to its acceptance results.
Buy the Kit21 CFR to ISO 13485 Mapping Kit
$199 USD · One-time · Applicable taxes may apply
- DMRDevice Master Record Quality system
A Device Master Record (DMR) is the full set of specifications, procedures and drawings needed to build, test, label and service a device.
Cross-device relevance
Why it matters for founders: Under QMSR it aligns with the ISO 13485 medical device file, so manufacturers often restructure their DMR during transition.
Buy the Kit21 CFR to ISO 13485 Mapping Kit
$199 USD · One-time · Applicable taxes may apply
- Establishment Registration and Device Listing Market access
FDA establishment registration identifies facilities involved in specified device activities; device listing identifies their devices and activities. Registration or listing does not mean that FDA has cleared, approved or endorsed a device or facility.
Cross-device relevance
Why it matters for founders: Determine obligations for your activity and maintain them separately from product authorization.
Related: Medical Device Commercialization, 510(k), PMA
- eSTARelectronic Submission Template And Resource Premarket
eSTAR is FDA's interactive PDF template for preparing medical device submissions such as 510(k)s and De Novo requests.
Cross-device relevance
Why it matters for founders: FDA requires eSTAR for most 510(k)s, and the template's built-in checks reduce the risk of an incomplete-submission hold.
- EU AI ActRegulation (EU) 2024/1689 AI and software
The EU's risk-based law on artificial intelligence; AI systems that are safety components of, or are, medical devices needing notified-body review are generally classed as high-risk.
Cross-device relevance
Why it matters for founders: High-risk obligations (risk management, data governance, human oversight, logging) add to EU MDR/IVDR requirements, with staged application dates.
Related: EU GDPR, NIST AI RMF
- EU GDPRGeneral Data Protection Regulation (EU) 2016/679 Risk and postmarket
The EU's data protection law; health data is a special category that needs a specific legal basis and extra safeguards.
Cross-device relevance
Why it matters for founders: AI tools processing EU patient data need lawful processing, data-protection impact assessments and controls on transfers outside the EU.
- EU MDREU Medical Device Regulation 2017/745 Market access
The EU MDR is Regulation (EU) 2017/745, the law that sets requirements for placing medical devices on the European Union market.
Cross-device relevance
Why it matters for founders: Most devices need a Notified Body certificate and stronger clinical evidence than under the old directives before CE marking.
- FDA AI-enabled device guidance AI and software
FDA's resources and guidance for AI-enabled medical devices, including its public list of authorized AI-enabled devices and recommendations on lifecycle management and PCCPs.
Cross-device relevance
Why it matters for founders: Buyers can confirm a product's FDA authorization and intended use, and check whether a PCCP covers future model updates.
Related: PCCP, GMLP, Procurement Readiness Score
- FedRAMPFederal Risk and Authorization Management Program Risk and postmarket
The US government program that standardizes security assessment and authorization of cloud services used by federal agencies.
Cross-device relevance
Why it matters for founders: Required for cloud AI tools sold to federal health systems such as the VA; also a strong security signal elsewhere.
- Form 483FDA Form 483, Inspectional Observations Quality system
A Form 483 lists the conditions an FDA investigator observed during an inspection that may violate FDA requirements.
Cross-device relevance
Why it matters for founders: A thorough response within 15 business days can help prevent escalation to a Warning Letter.
Related: Warning Letter, CAPA, QMSR
Buy the KitQMSR Form 483 Response Kit
$299 USD · One-time · Applicable taxes may apply
- GMLPGood Machine Learning Practice AI and software
Good Machine Learning Practice (GMLP) describes practices for safe, effective, high-quality AI/ML medical device development across the product life cycle. IMDRF published 10 guiding principles in January 2025, building on the FDA, Health Canada and MHRA principles from 2021; these principles are not a standalone certification or binding regulation.
SaMD and AI · IVD and diagnostics · Electrical and connected devices
Why it matters for founders: Reviewers look for GMLP themes — representative data, independent test sets, human-AI performance — in AI device submissions.
Buy the KitAI/ML PCCP Suite
$399 USD · One-time · Applicable taxes may apply
- Good Clinical Practice (GCP) Development and clinical
Good clinical practice describes ethical and scientific quality practices for clinical investigations, including protecting participants and producing credible data. ISO 14155 addresses clinical investigations of medical devices for human subjects.
Cross-device relevance
Why it matters for founders: Build consent, oversight and data-quality safeguards into a study before enrollment.
Related: IDE, Clinical Evidence
- Health Economics and Outcomes Research (HEOR) Market access
HEOR evaluates health outcomes, resource use, costs and the value of interventions. Studies may include economic evaluations and real-world outcomes analysis; it is an evidence discipline, not a regulatory clearance pathway.
Cross-device relevance
Why it matters for founders: It helps demonstrate value to payers and hospital purchasers beyond technical performance.
Related: Real-World Evidence (RWE), Reimbursement, Value Analysis Committee (VAC)
Buy the KitHospital VAC Dossier Pack
$299 USD · One-time · Applicable taxes may apply
- HIPAAHealth Insurance Portability and Accountability Act Risk and postmarket
US federal law whose Privacy, Security and Breach Notification Rules govern how covered entities and their business associates protect health information.
Cross-device relevance
Why it matters for founders: AI vendors that handle patient data usually sign a business associate agreement and must meet HIPAA Security Rule safeguards.
- Human Factors / Usability Engineering Risk and postmarket
Human factors (usability) engineering studies how intended users interact with a device to reduce use errors that could cause harm; IEC 62366-1 is the recognized standard.
Cross-device relevance
Why it matters for founders: FDA expects human factors validation data for devices with critical tasks, and use-related risks feed your ISO 14971 risk file.
Related: ISO 14971, Verification and Validation (V&V)
- IDEInvestigational Device Exemption Premarket
An Investigational Device Exemption (IDE) allows an investigational device to be used in a clinical study to collect safety and effectiveness data.
Cross-device relevance
Why it matters for founders: Significant-risk device studies need FDA IDE approval before enrollment; a Pre-Sub can help align on the study design first.
Related: Q-Sub (Pre-Sub), PMA
Buy the KitFDA Q-Sub Master Pack
$499 USD · One-time · Applicable taxes may apply
- IEC 60601-1Medical electrical equipment — basic safety and essential performance Premarket
IEC 60601-1 is the core international standard for the basic safety and essential performance of medical electrical equipment, supported by collateral and particular standards.
Electrical and connected devices · Implantable devices
Why it matters for founders: Powered devices usually need accredited-lab 60601 testing, which often sets the critical path for submission.
Related: Verification and Validation (V&V), ISO 14971
- IEC 62304Medical device software — Software life cycle processes AI and software
IEC 62304 is the international standard that defines life-cycle processes for developing and maintaining medical device software, scaled by software safety class.
SaMD and AI · IVD and diagnostics · Electrical and connected devices
Why it matters for founders: FDA recognizes it and EU Notified Bodies expect it, so aligning early avoids rework of software documentation.
- In Vitro Diagnostic (IVD) Premarket
An in vitro diagnostic is a reagent, instrument or system used to examine specimens taken from the human body to provide information about health, disease or other conditions.
IVD and diagnostics
Why it matters for founders: Diagnostic claims determine the performance studies, labeling and review pathway you need.
Related: Analytical Performance, Clinical Performance, Device Classification (Class I, II, III)
- Inpatient outlier payment Market access
Outlier payment is a separate Medicare inpatient mechanism for extraordinarily costly cases that meet the applicable fixed-loss threshold and payment conditions.
Cross-device relevance
Why it matters for founders: It is not routine reimbursement for an expensive implant and is distinct from NTAP eligibility and add-on payment. Use the applicable year's rules.
Related: NTAP, IPPS, Cost-to-charge ratio (CCR)
- Intended Use and Indications for Use Premarket
Intended use is the general purpose of a device; indications for use describe the disease or condition it diagnoses, treats, prevents or mitigates, and the target population.
Cross-device relevance
Why it matters for founders: These statements drive classification, predicate comparison, clinical evidence and what marketing claims you may make.
Related: 510(k), Substantial Equivalence, Labeling
Buy the KitFDA Q-Sub Master Pack
$499 USD · One-time · Applicable taxes may apply
- IPPSInpatient Prospective Payment System Market access
IPPS is Medicare's case-based payment system for many acute inpatient hospital stays, using MS-DRGs with hospital and case adjustments rather than paying separately for each device.
Cross-device relevance
Why it matters for founders: Confirm the care setting first: inpatient NTAP is not an outpatient payment mechanism or a direct payment to a device maker.
- IQ / OQ / PQInstallation, Operational and Performance Qualification Manufacturing and supply chain
IQ checks correct installation; OQ challenges operation across defined conditions; PQ demonstrates consistent performance under anticipated routine conditions. These are common qualification stages within a process-validation approach.
Cross-device relevance
Why it matters for founders: Qualification connects equipment setup and operating limits to repeatable production evidence.
- ISO 10993 (Biocompatibility) Premarket
ISO 10993-1 sets the framework for evaluating the biological safety of device materials that contact the body, within a risk management process.
Implantable devices · General medical devices · IVD and diagnostics · Electrical and connected devices
Why it matters for founders: FDA's biocompatibility guidance builds on ISO 10993-1; contact type and duration decide which tests you need.
Related: ISO 14971, Verification and Validation (V&V)
- ISO 13485ISO 13485:2016 Medical devices — Quality management systems Quality system
ISO 13485:2016 is the international standard that specifies quality management system requirements for organizations involved in the medical device life cycle.
Cross-device relevance
Why it matters for founders: FDA's QMSR incorporates ISO 13485 by reference, so one QMS can serve US, EU, Canada and other markets.
Related: QMSR, QMS, MDSAP, ISO 14971
Buy the Kit21 CFR to ISO 13485 Mapping Kit
$199 USD · One-time · Applicable taxes may apply
- ISO 14971ISO 14971:2019 Application of risk management to medical devices Risk and postmarket
ISO 14971:2019 is the international standard for identifying, evaluating, controlling and monitoring risks of medical devices throughout their life cycle.
Cross-device relevance
Why it matters for founders: FDA recognizes ISO 14971, and your risk file connects design inputs, verification, labeling and postmarket monitoring.
Related: ISO 13485, Design Controls, Postmarket Surveillance
- Labeling Risk and postmarket
Under FDA law, labeling includes the device label and all written, printed or graphic material accompanying the device, such as instructions for use.
Cross-device relevance
Why it matters for founders: Claims in labeling and promotion must stay within your cleared or approved indications.
Related: Intended Use and Indications for Use, UDI
- MDR (Medical Device Reporting) Risk and postmarket
Medical Device Reporting (21 CFR Part 803) requires manufacturers to report deaths, serious injuries and certain malfunctions involving their devices to FDA.
Cross-device relevance
Why it matters for founders: Most reportable events must be submitted within 30 calendar days, so complaint handling must flag them quickly. Not to be confused with the EU MDR.
Related: Postmarket Surveillance, CAPA, EU MDR
- MDSAPMedical Device Single Audit Program Quality system
MDSAP lets one recognized auditing organization audit a manufacturer's QMS against the requirements of the US, Canada, Brazil, Japan and Australia.
Cross-device relevance
Why it matters for founders: MDSAP is mandatory for Health Canada and can replace routine FDA inspections, reducing audit burden for multi-market companies.
Buy the KitCP 7382.850 Mock Inspection Kit
$299 USD · One-time · Applicable taxes may apply
- Medical Device Commercialization Market access
Commercialization is the practical transition from a developed device to lawful marketing, distribution and adoption. It combines applicable authorization and quality obligations with production capacity, sales, market access and ongoing support.
Cross-device relevance
Why it matters for founders: Clearance is one milestone; sustainable adoption also requires delivery capacity and customer evidence.
Related: Medical Device Manufacturing, Reimbursement, Value Analysis Committee (VAC), Establishment Registration and Device Listing
Buy the KitHospital VAC Dossier Pack
$299 USD · One-time · Applicable taxes may apply
- Medical Device Manufacturing Manufacturing and supply chain
Medical device manufacturing encompasses controlled activities that turn materials and components into finished devices, including production, inspection, packaging and release under the applicable quality system.
Cross-device relevance
Why it matters for founders: Scaling output must preserve specifications, traceability and validated processes.
Related: Design Transfer, Process Validation, DHR, Supplier Controls
- Medical Device Supply Chain Manufacturing and supply chain
The medical device supply chain is the network of organizations and activities that source materials, manufacture devices and deliver them to users. Quality issues, interruptions and shortages can affect availability and patient care.
Cross-device relevance
Why it matters for founders: Map critical dependencies and alternative supply options alongside supplier quality oversight.
Related: Supplier Controls, Contract Manufacturing, Supply Chain Resilience, Section 506J Shortage Notification
- Model Drift AI and software
Model drift describes changes over time in data or relationships that can reduce an AI model's performance in use. A changed data distribution does not always mean performance has degraded, so monitoring should evaluate both.
SaMD and AI · IVD and diagnostics · Electrical and connected devices
Why it matters for founders: Define monitoring thresholds and responses rather than assuming validation performance will persist indefinitely.
Related: GMLP, PCCP, Postmarket Surveillance
Buy the KitAI/ML PCCP Suite
$399 USD · One-time · Applicable taxes may apply
- MS-DRGMedicare Severity Diagnosis Related Group Market access
MS-DRGs group Medicare inpatient stays by diagnosis, procedure and severity; each group sets the hospital's fixed payment for the stay.
Cross-device relevance
Why it matters for founders: A new device's cost is usually absorbed in the DRG payment, so the DRG drives hospital economics and NTAP eligibility.
Related: NTAP, NTAP cost threshold
Buy the KitHospital VAC Dossier Pack
$299 USD · One-time · Applicable taxes may apply
- NIS 2Directive (EU) 2022/2555 Risk and postmarket
The EU directive setting cybersecurity risk-management and incident-reporting duties for essential and important entities, including healthcare providers and some medical device manufacturers.
Cross-device relevance
Why it matters for founders: EU hospitals must manage supply-chain cybersecurity risk, so they ask AI vendors for security and incident-response commitments.
- NIST AI RMFNIST AI Risk Management Framework (AI RMF 1.0) AI and software
A voluntary NIST framework, released in January 2023, that helps organizations manage AI risks through four functions: Govern, Map, Measure and Manage.
Cross-device relevance
Why it matters for founders: It is a common, vendor-neutral structure for hospital AI governance policies and vendor risk reviews.
Related: OECD AI Principles, EU AI Act, Procurement Readiness Score
- NIST CSFNIST Cybersecurity Framework 2.0 Risk and postmarket
NIST's voluntary cybersecurity framework; version 2.0 (2024) organizes outcomes into six functions: Govern, Identify, Protect, Detect, Respond and Recover.
Cross-device relevance
Why it matters for founders: Hospitals often map vendor and device security controls to CSF outcomes during procurement.
- Notified Body Market access
A Notified Body is an organization designated by an EU member state to assess whether medium- and high-risk devices conform to the EU MDR before CE marking.
Cross-device relevance
Why it matters for founders: Notified Body capacity and review times often set the timeline for EU launch.
Related: EU MDR, CE Marking, Clinical Evaluation Report (CER)
- NTAPNew Technology Add-on Payment Market access
NTAP is a temporary Medicare add-on paid to hospitals for qualifying inpatient cases involving approved new technologies. The traditional eligibility criteria are newness, cost and substantial clinical improvement, with specified transitional pathway exceptions.
Cross-device relevance
Why it matters for founders: It may offset some additional case costs, but does not guarantee coverage, hospital profit or two to three paid years after approval. NTAP Analyzer supports cost-criterion planning, not a complete eligibility or payment determination.
Related: NTAP cost threshold, MS-DRG, NTAP newness, Substantial clinical improvement (SCI)
Buy the KitNTAP Master Workbook
$499 USD · One-time · Applicable taxes may apply
- NTAP alternative pathway and grandfathering Market access
Alternative pathways provide specified eligibility treatment for qualifying categories. The FY 2027 final rule repeals them for FY 2028 applications except specified transitional provisions through FY 2029.
Cross-device relevance
Why it matters for founders: Breakthrough designation does not guarantee NTAP. Confirm category, designation and authorization dates, indication, cost evidence and annual deadlines against current CMS rules.
Related: NTAP, Breakthrough Device Designation, Substantial clinical improvement (SCI)
- NTAP cost threshold Market access
A CMS-published comparison value used to assess estimated standardized case charges for the NTAP cost criterion, using the relevant MS-DRGs and applicable case weighting. It is not the device price or the hospital's DRG payment.
Cross-device relevance
Why it matters for founders: Use the threshold file for the target application cycle, including corrections, rather than relying on the label Table 10 alone. The Analyzer pre-fills reference thresholds; a favorable screen is not CMS approval.
Related: NTAP, MS-DRG, NTAP standardized case charges, Cost-to-charge ratio (CCR)
Buy the KitNTAP Master Workbook
$499 USD · One-time · Applicable taxes may apply
- NTAP newness Market access
Newness assesses whether a technology is still new for Medicare inpatient payment, considering coding, available data for DRG recalibration and substantial similarity to existing technology.
Cross-device relevance
Why it matters for founders: FDA authorization alone does not establish newness, and the two-to-three-year framework does not guarantee that many years of payment after NTAP approval.
Related: NTAP, Substantial clinical improvement (SCI)
- NTAP payment limit Market access
For qualifying discharges, the general NTAP payment is limited to the lesser of 65% of technology costs or 65% of case costs above the relevant DRG payment, subject to approved limits and claim requirements. Specified categories have 75% rules.
Cross-device relevance
Why it matters for founders: The percentage is not applied directly to gross charges, and the maximum approved add-on is not guaranteed payment on every case. The Analyzer is not a claim-payment or margin calculator.
Related: NTAP, NTAP cost threshold, Cost-to-charge ratio (CCR)
- NTAP standardized case charges Market access
For the NTAP cost criterion, CMS assesses estimated charges for cases involving a technology with applicable standardization and relevant DRG weighting, not the device selling price alone.
Cross-device relevance
Why it matters for founders: Include the relevant stay and replacement effects, document the baseline and use the correctly labeled application threshold file and corrections.
Related: NTAP cost threshold, Cost-to-charge ratio (CCR), MS-DRG
- OECD AI Principles AI and software
Intergovernmental principles adopted in 2019 (updated 2024) promoting AI that is innovative, trustworthy and respects human rights and democratic values, including transparency, robustness and accountability.
Cross-device relevance
Why it matters for founders: They underpin many national AI policies and give governance committees shared language for responsible AI.
Related: NIST AI RMF, EU AI Act
- Patient Registry Development and clinical
A patient registry is an organized system collecting data about people with a condition, exposure or treatment to evaluate specified outcomes. Registries can be a source of real-world data when information is routinely collected.
Cross-device relevance
Why it matters for founders: Define outcomes, follow-up and data quality early if registry data will support device evidence.
Related: Real-World Data (RWD), Real-World Evidence (RWE), Clinical Evidence
- Payer Coverage Market access
Payer coverage is a health plan's determination of whether a service or product is eligible for benefits under specified conditions. Medicare uses national and local coverage decisions for many services.
Cross-device relevance
Why it matters for founders: A billing code alone does not demonstrate that a payer will cover a device-related service.
Related: Reimbursement, CPT and HCPCS codes, Clinical Evidence
Buy the KitReimbursement & Coding Roadmap
$299 USD · One-time · Applicable taxes may apply
- PCCPPredetermined Change Control Plan AI and software
A Predetermined Change Control Plan (PCCP) is the part of a marketing submission that describes planned device modifications, how they will be developed and validated, and their impact assessment, so authorized changes can be made without a new submission.
SaMD and AI · IVD and diagnostics · Electrical and connected devices
Why it matters for founders: For AI/ML devices, an authorized PCCP lets you update models faster — but every change must still be executed under your quality system.
Buy the KitAI/ML PCCP Suite
$399 USD · One-time · Applicable taxes may apply
- Periodic Safety Update Report (PSUR) Risk and postmarket
Under EU MDR Article 86, the PSUR summarizes postmarket data analysis, benefit-risk conclusions and preventive or corrective actions for Class IIa, IIb and III devices. Update frequency depends on class; IVDR has separate provisions for Class C and D IVDs.
SaMD and AI · Implantable devices · Electrical and connected devices · General medical devices
Why it matters for founders: Allocate owners and a reporting schedule for postmarket evidence before launch.
Related: Post-Market Clinical Follow-up (PMCF), EU MDR, Postmarket Surveillance
- PMAPremarket Approval Premarket
Premarket Approval (PMA) is FDA's most stringent review pathway, requiring valid scientific evidence that a Class III device is safe and effective.
Cross-device relevance
Why it matters for founders: PMAs usually need clinical data and a pre-approval inspection, so timelines and costs are much higher than a 510(k).
Related: IDE, 510(k), Q-Sub (Pre-Sub)
Buy the KitFDA Q-Sub Master Pack
$499 USD · One-time · Applicable taxes may apply
- Post-Market Clinical Follow-up (PMCF) Risk and postmarket
Under the EU MDR, PMCF is a continuous process that updates clinical evaluation by collecting and evaluating clinical data from use of a CE-marked device within its intended purpose. The plan must address the need for PMCF or justify why it is not applicable.
SaMD and AI · Implantable devices · Electrical and connected devices · General medical devices
Why it matters for founders: Plan ongoing clinical evidence collection and incorporate findings into clinical evaluation and risk management.
Related: Clinical Evaluation Report (CER), EU MDR, Postmarket Surveillance
- Postmarket SurveillancePost-Market Surveillance (PMS) Risk and postmarket
Postmarket surveillance is the active, systematic collection, analysis and interpretation of information about a marketed device's safety and performance. General lifecycle monitoring is distinct from an FDA section 522 surveillance order, which can require studies for certain Class II or III devices.
Cross-device relevance
Why it matters for founders: It feeds complaint handling, risk files, CAPA and — for AI devices — model performance monitoring.
Related: MDR (Medical Device Reporting), CAPA, ISO 14971
- Predicate Device Premarket
A predicate device is a legally marketed device that a 510(k) compares a new device against to show substantial equivalence.
Cross-device relevance
Why it matters for founders: Choosing the right predicate determines which differences you must explain and what performance data FDA will expect.
Related: 510(k), Substantial Equivalence
Buy the KitFDA Q-Sub Master Pack
$499 USD · One-time · Applicable taxes may apply
- Process Validation Manufacturing and supply chain
Process validation establishes documented evidence that a process consistently produces results meeting specified requirements. ISO 13485 requires validation where the resulting output cannot be, or is not, verified by subsequent monitoring or measurement.
Cross-device relevance
Why it matters for founders: Sterilization, bonding and other special processes may need validation before commercial release.
Related: Medical Device Manufacturing, IQ / OQ / PQ, Sterilization Validation
- Procurement Readiness ScorePRS AI and software
Cahir's Procurement Readiness Score (PRS) is a 100-point score that weights an AI-enabled medical device's clinical (40%), technical (35%) and operational (25%) evidence and places it in a Ready, Conditional or Not ready band.
Cross-device relevance
Why it matters for founders: It gives hospital committees one comparable view of vendors before contracting, instead of relying on demos.
Related: NIST AI RMF, FDA AI-enabled device guidance
- Product Code Premarket
An FDA product code is a three-letter identifier tied to a device type's classification regulation, class and review panel.
Cross-device relevance
Why it matters for founders: Searching FDA databases by product code is the fastest way to find predicates, recognized standards and competitor clearances.
Related: Device Classification (Class I, II, III), Predicate Device
- Q-Sub (Pre-Sub)Q-Submission / Pre-Submission Premarket
A Q-Submission (Q-Sub) is a formal request for FDA feedback; the Pre-Submission type lets you ask specific questions about your planned testing or submission before you file.
Cross-device relevance
Why it matters for founders: Well-framed questions get actionable written feedback that can prevent costly testing or pathway mistakes.
Buy the KitFDA Q-Sub Master Pack
$499 USD · One-time · Applicable taxes may apply
- QMSQuality Management System Quality system
A quality management system (QMS) is the documented set of processes, responsibilities and records a company uses to consistently make safe, effective devices.
Cross-device relevance
Why it matters for founders: A right-sized QMS started early is cheaper than retrofitting one before submission or inspection.
Related: ISO 13485, QMSR, CAPA
Buy the Kit21 CFR to ISO 13485 Mapping Kit
$199 USD · One-time · Applicable taxes may apply
- QMSRQuality Management System Regulation Quality system
The QMSR is FDA's amended 21 CFR Part 820, effective February 2, 2026, which incorporates ISO 13485:2016 by reference as the US device quality system requirement.
Cross-device relevance
Why it matters for founders: It replaced the old Quality System Regulation; FDA now inspects to ISO 13485 plus US-specific requirements.
Related: ISO 13485, QMS, DHF, Form 483
Buy the Kit21 CFR to ISO 13485 Mapping Kit
$199 USD · One-time · Applicable taxes may apply
- Real-World Data (RWD) Development and clinical
Real-world data are data about patient health status or delivery of health care routinely collected from sources such as health records, claims, registries and devices. Analysis of fit-for-purpose RWD can generate real-world evidence.
Cross-device relevance
Why it matters for founders: Data availability alone does not establish relevance, reliability or suitability for a regulatory question.
Related: Real-World Evidence (RWE), Patient Registry, Postmarket Surveillance
- Real-World Evidence (RWE) Risk and postmarket
Real-world evidence is clinical evidence about a device's use, benefits or risks derived from analyzing real-world data such as registries, health records and claims.
Cross-device relevance
Why it matters for founders: FDA may accept RWE to support some premarket and postmarket decisions when the data are relevant and reliable.
Related: Postmarket Surveillance, IDE, Real-World Data (RWD)
- Recall Risk and postmarket
A recall is a firm's removal or correction of a marketed device that FDA considers violative; FDA classifies recalls as Class I, II or III by health risk.
Cross-device relevance
Why it matters for founders: Corrections and removals may also require a report to FDA under 21 CFR Part 806.
Related: CAPA, UDI, Postmarket Surveillance
- Reimbursement Market access
Reimbursement is payment by a payer for a health service, procedure or product under its rules. Coding identifies what was provided, coverage decides eligibility for benefits, and payment determines the amount and method.
Cross-device relevance
Why it matters for founders: FDA authorization does not guarantee coverage or payment; plan the economic evidence separately.
Related: CPT and HCPCS codes, Payer Coverage, Value Analysis Committee (VAC)
Buy the KitReimbursement & Coding Roadmap
$299 USD · One-time · Applicable taxes may apply
- Requirements Traceability Matrix (RTM) Development and clinical
A requirements traceability matrix is a practical way to link user needs, design inputs, outputs, risk controls and verification or validation evidence. The matrix is a documentation tool, not a universally mandated file format.
Cross-device relevance
Why it matters for founders: It reveals missing evidence and makes change impact reviews easier.
Related: Design Inputs, Verification and Validation (V&V), ISO 14971
- SaMDSoftware as a Medical Device AI and software
Software as a Medical Device (SaMD) is software intended for medical purposes that performs those purposes without being part of a hardware device.
SaMD and AI · IVD and diagnostics · Electrical and connected devices
Why it matters for founders: SaMD still needs design controls, cybersecurity documentation and, often, a premarket submission.
Buy the KitAI/ML PCCP Suite
$399 USD · One-time · Applicable taxes may apply
- SBOMSoftware Bill of Materials AI and software
A software bill of materials (SBOM) lists the commercial, open-source and off-the-shelf software components in a device.
SaMD and AI · IVD and diagnostics · Electrical and connected devices
Why it matters for founders: FDA requires an SBOM in premarket submissions for cyber devices under section 524B of the FD&C Act.
- Section 506J Shortage Notification Manufacturing and supply chain
Section 506J requires manufacturers of certain devices to notify FDA of specified discontinuances or manufacturing interruptions likely to meaningfully disrupt US supply during or in advance of a public health emergency. FDA also accepts voluntary notifications outside that context.
Cross-device relevance
Why it matters for founders: Check the current 506J device list and notification criteria; this is not a universal duty for every routine delay.
Related: Medical Device Supply Chain, Medical Device Manufacturing
- Shelf Life Manufacturing and supply chain
Shelf life is the period during which a device is expected to remain within specified safety and performance requirements under defined storage conditions. Evidence may address material stability, reagent performance or sterile-barrier integrity.
IVD and diagnostics · Implantable devices · General medical devices · Electrical and connected devices
Why it matters for founders: Expiry claims affect testing, inventory planning and packaging decisions.
Related: Sterilization Validation, Verification and Validation (V&V), Labeling
- SOC 2 Risk and postmarket
An AICPA attestation report in which an independent auditor evaluates a service organization's controls for security, availability, processing integrity, confidentiality and privacy.
Cross-device relevance
Why it matters for founders: A SOC 2 Type II report is common evidence in vendor security reviews of cloud-hosted AI tools.
- Sterilization Validation Manufacturing and supply chain
Sterilization validation demonstrates that a defined sterilization process can consistently achieve the specified sterility assurance level for the product and its packaging. Applicable standards depend on the sterilization method.
Implantable devices · General medical devices · IVD and diagnostics · Electrical and connected devices
Why it matters for founders: Changes to materials, packaging or the process may require evaluation and revalidation.
Related: Process Validation, ISO 10993 (Biocompatibility), Shelf Life
- Substantial clinical improvement (SCI)NTAP substantial clinical improvement Market access
SCI is CMS's assessment of a meaningful advance in diagnosis or treatment compared with previously available options for Medicare beneficiaries, using the totality of relevant evidence.
Cross-device relevance
Why it matters for founders: A favorable cost screen or FDA authorization does not establish SCI. The Analyzer evaluates cost-criterion planning, not clinical eligibility.
Related: NTAP, Clinical Evidence, NTAP alternative pathway and grandfathering
- Substantial Equivalence Premarket
Substantial equivalence means a new device has the same intended use as its predicate and either the same technological characteristics or differences that do not raise different safety and effectiveness questions.
Cross-device relevance
Why it matters for founders: It is the legal standard FDA applies in every 510(k) decision.
Related: 510(k), Predicate Device
Buy the KitFDA Q-Sub Master Pack
$499 USD · One-time · Applicable taxes may apply
- Supplier Controls Quality system
Supplier (purchasing) controls are the QMS processes for evaluating, selecting, monitoring and documenting suppliers based on their effect on device quality.
Cross-device relevance
Why it matters for founders: Contract manufacturers and critical component suppliers are your responsibility; investigators frequently cite weak supplier oversight.
Buy the Kit21 CFR to ISO 13485 Mapping Kit
$199 USD · One-time · Applicable taxes may apply
- Supply Chain Resilience Manufacturing and supply chain
Supply chain resilience is the ability to anticipate, withstand and recover from supply disruptions while maintaining access to safe, effective devices. It can include risk assessment, qualified alternatives and continuity planning.
Cross-device relevance
Why it matters for founders: A single critical supplier can become a launch or patient-access bottleneck.
Related: Medical Device Supply Chain, Supplier Controls, Section 506J Shortage Notification
- Total Product Life Cycle (TPLC) Development and clinical
The total product life cycle covers a device from concept and development through manufacturing, marketing, use, monitoring and eventual retirement. Evidence from later stages informs earlier design and risk decisions.
Cross-device relevance
Why it matters for founders: Plan for production and postmarket evidence before launch, rather than treating clearance as the finish line.
Related: Design Controls, Medical Device Manufacturing, Postmarket Surveillance
- UDIUnique Device Identification Risk and postmarket
Unique Device Identification (UDI) is FDA's system requiring device labels to carry a unique identifier, with device data submitted to the GUDID database.
Cross-device relevance
Why it matters for founders: UDI supports recalls, adverse event reporting and hospital supply chains, and must be planned into labeling.
Related: DHR, Postmarket Surveillance
- UKCAUK Conformity Assessed Market access
UKCA is the conformity marking for placing medical devices on the Great Britain market, overseen by the MHRA.
Cross-device relevance
Why it matters for founders: Transitional arrangements currently allow CE-marked devices in Great Britain, but timelines should be checked against current MHRA guidance.
Related: EU MDR
- Value Analysis Committee (VAC) Market access
A hospital value analysis committee (VAC) is the group of clinical, supply chain and finance staff that decides whether to purchase a new product.
Cross-device relevance
Why it matters for founders: Clinical evidence alone rarely wins; VACs expect budget impact, workflow and outcome data.
Related: CPT and HCPCS codes
Buy the KitHospital VAC Dossier Pack
$299 USD · One-time · Applicable taxes may apply
- Verification and Validation (V&V) Quality system
Design verification confirms that design outputs meet design inputs; design validation confirms that the finished device meets user needs and intended uses.
Cross-device relevance
Why it matters for founders: V&V results are the core test evidence in a premarket submission and in your design records.
Related: Design Controls, DHF, Human Factors / Usability Engineering
- Warning Letter Quality system
An FDA Warning Letter is a public notice that FDA considers a company to be in significant violation of regulatory requirements.
Cross-device relevance
Why it matters for founders: Warning Letters are published and can block certificates to foreign governments and premarket approvals until resolved.
Buy the KitQMSR Form 483 Response Kit
$299 USD · One-time · Applicable taxes may apply
Definitions are plain-language summaries for orientation, not legal or regulatory advice. Always confirm against the linked official source.
Ready to put these terms to work?
Practical workbooks turn PCCP, QMSR, Q-Sub and inspection requirements into owned, evidence-backed tasks.

